RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,553,143 | -10.2% | 987,339 | -12.3% | 0.00% | 0.0% |
| Q2 2023 | $8,408,568 | +122832.3% | 1,125,645 | +9.8% | 0.00% | 0.0% |
| Q1 2023 | $6,840 | -22.7% | 1,025,585 | -10.6% | 0.00% | 0.0% |
| Q4 2022 | $8,847 | -99.9% | 1,147,429 | +35.4% | 0.00% | -25.0% |
| Q3 2022 | $9,014,000 | +94.7% | 847,137 | +49.0% | 0.00% | +100.0% |
| Q2 2022 | $4,629,000 | +59.1% | 568,582 | +29.4% | 0.00% | +100.0% |
| Q1 2022 | $2,909,000 | -56.4% | 439,460 | +18.7% | 0.00% | -50.0% |
| Q4 2021 | $6,675,000 | +171.0% | 370,206 | +302.9% | 0.00% | +100.0% |
| Q3 2021 | $2,463,000 | -14.3% | 91,883 | +16.7% | 0.00% | 0.0% |
| Q2 2021 | $2,873,000 | – | 78,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
| Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
| MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
| MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
| ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
| Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
| ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
| Artal Group S.A. | 960,204 | $7,403 | 0.41% |